Haojiang Dai
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Liver Disease and Transplantation 1
- Surgery 1
- Organ Transplantation Techniques and Outcomes 1
- Co-authors
- Shusen Zheng (7 shared papers)Xiao Xu (5 shared papers)Haiyang Xie (6 shared papers)Qiaonan Shan (4 shared papers)Penghong Song (4 shared papers)Sunbin Ling (2 shared papers)Zhikun Liu (1 shared paper)Lin Zhou (1 shared paper)
- Journals
- Journal of Hematology & Oncology (1 paper)Scientific Reports (1 paper)Molecular Oncology (1 paper)Cancer Biomarkers (1 paper)Batteries (1 paper)
- Partner nations
- ChinaMadagascarUnited Kingdom
In The Last Decade
Haojiang Dai
9 papers receiving 326 citations
Peers
Comparison fields: 5 of 64
- Hepatology 32
- Cancer Research 59
- Geriatrics and Gerontology 9
- Molecular Biology 180
- Oncology 58
Countries citing papers authored by Haojiang Dai
This map shows the geographic impact of Haojiang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojiang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojiang Dai more than expected).
Fields of papers citing papers by Haojiang Dai
This network shows the impact of papers produced by Haojiang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojiang Dai. The network helps show where Haojiang Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Haojiang Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 101 | |
| 2 | 2017 | 86 | |
| 3 | 2017 | 62 | |
| 4 | 2024 | 25 | |
| 5 | 2016 | 19 | |
| 6 | 2017 | 17 | |
| 7 | 2020 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2025 | 3 |
About Haojiang Dai
Haojiang Dai is a scholar working on Hepatology, Surgery, Molecular Biology, Oncology and Epidemiology, having authored 9 papers that have together received 328 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (1 paper), Advanced battery technologies research (1 paper), Ubiquitin and proteasome pathways (1 paper), Protease and Inhibitor Mechanisms (1 paper), Cancer-related Molecular Pathways (1 paper), Liver Disease and Transplantation (1 paper), Supercapacitor Materials and Fabrication (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hepatology (32 citations), Cancer Research (59 citations), Geriatrics and Gerontology (9 citations), Molecular Biology (180 citations) and Oncology (58 citations). Haojiang Dai has collaborated with scholars based in China, Madagascar and United Kingdom. Frequent co-authors include Shusen Zheng, Xiao Xu, Haiyang Xie, Qiaonan Shan, Penghong Song, Sunbin Ling, Zhikun Liu, Lin Zhou, Jun Chen and Jie Li. Their work appears in journals such as Journal of Hematology & Oncology, Scientific Reports, Molecular Oncology, Cancer Biomarkers and Batteries.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.